• Provides comprehensive understanding of peanut allergy active therapeutics pipeline drug candidates
• Includes all-inclusive pipeline product coverage with segregation by various stages of the pipeline from discovery to late-stage.
• Offers pipeline assessment by monotherapy, combination therapy products, and route of administration
• Provides a comparative analysis of key marketed products and pipeline drug candidates
• Includes detailed pipeline drug profiles covering – product description, chemical information, molecule type, mechanism of action, route of administration, product safety and efficacy, developers and collaborators
• Provides key info on players involved in clinical R&D of peanut allergy therapeutics drug candidates.
• Provides in-depth coverage of key news related to peanut allergy therapeutics drug molecules, including major mergers and acquisitions and product development updates such as clinical trial progression updates and regulatory updates.
• To obtain an understanding of the current cataract therapeutics pipeline landscape.
• To determine drug development dynamics and leverage it for innovation of novel or repositioned drugs.
• To valuably optimize R&D activities in-line with robust therapeutic drug markets.
• To devise strategic initiatives by identifying prospective partners with progressing projects.
20% Discount Applied*
Get your free sample proposal with a single click!